14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 158 days ( -82.00 % )
Last Price $38.22 0 %
High/ Low $38.22 - $38.22 0%
Chg 7 Days N/A $38.22 $38.22
Chg 30 Days N/A $38.22 $38.22
Chg 12 mos 21.33 % $31.50 $38.22
Trend - 3 mos N/A Width: 0.00000000 %
Trend - 12 mos 30.44 % Width: 86.96 %
Pred. range - 3 mos $38.22 - $38.22 0 % - 0 %
Pred. range - 12 mos $34.92 - $65.29 -8.64 % - 70.82 %
Short MA avg 3 mos Sell Nov 30, -1 - N/A days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Buy Dec 20, 2021 - 111 days
Long MA avg 12 mos Buy Nov 17, 2021 - 133 days
Short/Long MA avg 12 mos Buy Nov 19, 2021 - 131 days
Pivot Short Sell May 26, 2022 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Dicerna Pharmaceuticals

Dicerna Pharmaceuticals Dicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery and development of treatments for liver diseases and cancers based on a proprietary RNA interference technology platform in the United States and internationally. The company’s development programs include DCR-PH1 for the treatment of primary hyperoxaluria type 1 (PH1) through targeting the gene encoding the liver enzyme glycolate oxidase; and other rare inherit... DRNA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT